Strategic Growth Drivers Shaping the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Outlook 2025- 2034:Increase In The Number Of Prostate Cancer In Benign Prostatic Hyperplasia Market
Discover trends, market shifts, and competitive outlooks for the benign prostatic hyperplasia (bph) treatment devices and equipment industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
How Has The Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Growth Evolved From 2024 To 2025, And What’s Ahead?
Over the recent years, the market size for benign prostatic hyperplasia (BPH) treatment devices and equipment has seen robust growth. It’s forecasted to increase from $1.29 billion in 2024 to $1.38 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.2%. The historic growth can be linked to factors such as an aging population, increased awareness and diagnostics, healthcare accessibility, and personalized treatment methods.
The market size for treatment devices and equipment of benign prostatic hyperplasia (BPH) is predicted to experience robust expansion in the forthcoming years. It aims to reach $1.8 billion by 2029, with a compound annual growth rate (CAGR) of 6.8%. This anticipated growth during the forecast period can be attributed to the adoption of minimally invasive procedures, growth in emerging markets, regulatory backing, and value-driven healthcare. Key trends during this forecast period entail non-surgical and office-based procedures, the use of laser and radiofrequency technologies, the application of telemedicine and remote consultations, and heightened patient education and participation.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2431&type=smp
Which Factors and External Forces Are Driving Demand in the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market?
The benign prostatic hyperplasia market is expected to be fueled by the growing number of prostate cancer incidences. Prostate cancer is a type of cancer that originates in the prostate gland, a small organ the size of a walnut situated immediately below the bladder in men. The rise in prostate cancer incidences often leads to more elderly men seeking help for prostate-related conditions. Consequently, this leads to the detection and treatment of benign prostatic hyperplasia. For example, in February 2023, the American Society of Clinical Oncology (ASCO), a professional organization based in the US that shares patient information on its cancer.net website, estimated that there were approximately 288,300 men with prostate cancer in the US in 2023, and there were 268,490 new cases and 34,500 deaths from prostate cancer in 2022. Therefore, the benign prostatic hyperplasia market is being propelled by the escalating number of prostate cancer cases.
Which Segments in the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Offer the Most Growth?
The benign prostatic hyperplasia (BPH) treatment devices and equipment market covered in this report is segmented –
1) By Product: Resectoscopes, Radiofrequency Ablation Device, Urology Lasers, Prostatic Stents, Implants
2) By Procedure Type: Transurethral Needle Ablation (TUNA), Transurethral Resection Of Prostate (TURP), Transurethral Incision Of Prostate (TUIP), Transurethral Microwave Thermotherapy (TUMT), Laser Surgery, Other Procedure Types
3) By End-User: Hospitals, Ambulatory Surgical Centres (ASC), Clinics, Home
Subsegments:
1) By Resectoscopes: Bipolar Resectoscopes, Monopolar Resectoscopes, High-Performance Resectoscopes
2) By Radiofrequency Ablation Device: Single-Needle Radiofrequency Ablation, Multi-Needle Radiofrequency Ablation
3) By Urology Lasers: Holmium Lasers, Diode Lasers, Green Light Lasers
4) By Prostatic Stents: Temporary Prostatic Stents, Permanent Prostatic Stents
5) By Implants: Prostatic Urethral Lift (PUL) Implants, Balloon-Expandable Stents, Permanent Implants for BPH Treatment
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=2431&type=smp
What Are the Fastest-Growing Geographies in the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market?
North America was the largest region in the benign prostatic hyperplasia (BPH) treatment devices and equipment market in 2023. Western Europe was the second-largest region in the global benign prostatic hyperplasia (BPH) treatment devices and equipment market. The regions covered in the benign prostatic hyperplasia (BNH) treatment devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Which Cutting-Edge Market Trends Are Expected to Drive the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market’s Growth?
Key players in the benign prostatic hyperplasia market are concentrating their efforts on creating innovative products including the UroLift 2 System and UroLift ATC advanced tissue control system. These systems have been designed to guarantee dependable solutions within the market. Both UroLift 2 and UroLift ATC systems have been introduced to treat lower urinary tract signs resulting from benign prostatic hyperplasia (BPH), a condition also known as an enlarged prostate. In May 2022, for example, the U.S. medical device company Teleflex Incorporated unveiled both the UroLift 2 and UroLift ATC systems. The UroLift 2 system is an advanced delivery system devised to reach the prostatic urethra and install permanent UroLift implants within the prostate lobes. On the other hand, the UroLift ATC advanced tissue control system offers a minimally invasive treatment option for enlarged prostate symptoms. These systems mark a significant advancement in managing benign prostatic hyperplasia (BPH) by lifting and retaining the enlarged prostate tissue so it no longer obstructs the urethra.
View the full report here:
What Are the Key Elements That Define the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market?
Benign prostatic hyperplasia or benign prostatic hypertrophy is a condition of prostate gland enlargement which causes blockade of urethra, the tube that carries urine from the bladder.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2431
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
